Abbott Laboratories
DE ˙ XTRA ˙ US0028241000
75,22 € ↑1,20 (1,62%)
2026-06-03
AKTIENPREIS
SecurityDE:ABL / Abbott Laboratories
InstitutionXTX Topco Ltd
Latest Disclosed Ownership139,664 shares
Latest Disclosed Value $ 14,339,303
XTX Topco Ltd reports 178.64% increase in ownership of ABL / Abbott Laboratories

On May 15, 2026 - XTX Topco Ltd filed a 13F-HR form disclosing ownership of 139,664 shares of Abbott Laboratories (DE:ABL) valued at $12,404,956 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 50,123 shares of Abbott Laboratories. This represents a change in shares of 178.64% during the quarter. The current value of the position is $10,505,526 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ABBOTT LABORATORIES COM 002824100 139,664 89,541 178.64 14,339 128.36 0.2493
2026-02-17 2025-12-31 13F ABBOTT LABS COM 002824100 50,123 18,560 58.80 6,280 48.55 0.1649
2025-11-14 2025-09-30 13F ABBOTT LABS COM 002824100 31,563 31,563 4,228 0.2194
2025-05-08 2025-03-31 13F ABBOTT LABS COM 002824100 0 -28,053 -100.00 0 -100.00
2025-02-13 2024-12-31 13F ABBOTT LABS COM 002824100 28,053 26,202 1,415.56 3,173 1,403.79 0.2608
2024-11-14 2024-09-30 13F ABBOTT LABS COM 002824100 1,851 -31,480 -94.45 211 -93.91 0.0153
2024-08-12 2024-06-30 13F ABBOTT LABS COM 002824100 33,331 29,150 697.20 3,463 629.05 0.2965
2024-05-13 2024-03-31 13F ABBOTT LABS COM 002824100 4,181 4,181 475 0.0641
2023-11-13 2023-09-30 13F ABBOTT LABS COM 002824100 0 -1,945 -100.00 0 -100.00
2023-08-14 2023-06-30 13F ABBOTT LABS COM 002824100 1,945 1,945 212 0.0380
2022-08-15 2022-06-30 13F ABBOTT LABS COM 002824100 0 -6,056 -100.00 0 -100.00
2022-05-13 2022-03-31 13F ABBOTT LABS COM 002824100 6,056 6,056 717 0.3144
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.